1PATERSON D J,JEFFERIES W A,GREEN J R,et al.Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts[J].Mol Immunol,1987,24(12):1281-1290.
2CROFT M.Control of immunity by the TNFR-related molecule OX40(CD134)[J].Annu Rev Immunol,2010,28:57-78.
3SALEK-ARDAKANI S,CROFT M.Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity[J].J Interferon Cytokine Res,2010,30(4):205-217.
4CROFT M,SO T,DUAN W,et al.The significance of OX40 and OX40L to T-cell biology and immune disease[J].Immunol Rev,2009,229(1):173-191.
5SALEK-ARDAKANI S,FLYNN R,ARENS R,et al.The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice[J].J Clin Invest,2011,121(1):296-307.
6CHEN M,XIAO X,DEMIRCI G,et al.OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs[J].Transplantation,2008,85(11):1659-1662.
7JUTEL M,AKDIS C A.T-cell subset regulation in atopy[J].Curr Allergy Asthma Rep,2011,11(2):139-145.
8LUBERTS E.Th17 cytokines and arthritis[J].Semin Immunopathol,2010,32(1):43-53.
9PILAT N,SAYEGH M H,WEKERLE T.Costimulatory pathways in transplantation[J].Semin Immunol,2011,23(4):293-303.
10SOROOSH P,INE S,SUGAMURA K.Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells[J].J Immunol,2007,179(8):5014-5023.
二级参考文献16
1Libby P. Inflammation in atherosclerosis [ J ]. Nature, 2002,420 (6917) :868-874.
2Libby P, Redker P M, Maseri A. Inflammation and atherosclerosis [ J ]. Circulation, 2002,105 ( 9 ) : 1135-1143.
3Chyu K Y, Shah P K. The role of inflammation in plaque disruption and thrombosis [ J ]. Rev Cardiovasc Med, 2001,2 ( 2 ) : 82-91.
4Mendel I, Shevach E M. Activated T cells express the OX40 ligand: requirmentsfor induction and costimulatory function [ J ]. Immunology,2006,117 ( 2 ) : 196- 204.
5Croft M. Co-stimulatory members of the TNFR family:keys to effective T-cellimmunity? [ J ] Nat Rev Immunol,2003,3 ( 8 ) : 609-620.
6Sugamura K, Ishii N, Weinberg A D. Therapeutic targeting if the effector T-cell co-stimulatory molecule OX40 [ J ]. Nat Rev Immunol, 2004,4 ( 6 ) : 420 - 431.
7Van Wanrooij E J,Van Puijvelde G H, De Vos P, et al. Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-densitylipoprotein receptor-deficient mice[J]. Arterioscler Throm Vasc Biol,2007,27( 1 ) :204-210.
8Ria M, Eriksson P, Boquist S. Human genetic evidence that OX40 is implicated in myocardial infarction [ J ]. Biochem Biophys Res Commun, 2006,339 (3) : 1001 - 1006.
9Yan J C,Zhu J,Gao L,et al. The effect of elevated serum soluble CD40 ligand on the prognotic value in patients with acute coronary syndromes [ J ]. Clin Chin Acta, 2004,343 ( 1- 2 ) : 155-159.
10Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [ J ]. N Engl J Med, 2000,342 (12) :836-843.
4Bombardier C,Gladman D D,Urowitz M B,et al.Derivation of the SLEDAI.A disease activity index for lupus patients[J].Arthritis&Rheumatism,1992,35(6):630-640.
5Maxwell J R,Weinberg A,Prell R A,et al.Danger and OX40receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion[J].The Journal of Immunology,2000,164(1):107-112.
6Weinberg A D,Vella A T,Croft M.OX-40:life beyond the effector T cell stage[C]//Seminars in immunology.Pittsburgh:Academic Press,1998,10(6):471-480.
7Yan J,Chen G,Gong J,et al.Upregulation of OX40-OX40ligand system on T lymphocytes in patients with acute coronary syndromes[J].Journal of Cardiovascular Pharmacology,2009,54(5):451-455.
8Zhou Y B,Ye R G,Li Y J,et al.Targeting the CD134-CD134Linteraction using anti-CD134 and/or rh CD134 fusion protein as a possible strategy to prevent lupus nephritis[J].Rheumatology International,2009,29(4):417-425.
9Rostoker D G.Sch?nlein-Henoch Purpura in children and adults[J].Biodrugs,2001,15(2):99-138.
10Goldstein A R,White R H R,Akuse R,et al.Long-term follow-up of childhood Henoch-Sch?nlein nephritis[J].Lancet,1992,339(8788):280-282.
